The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Dolby Laboratories Inc

NYSE: DLB
Last

(U.S.) $40.17

Today's change0.00 0.00%
Updated January 26 4:02 PM EST. Delayed by at least 15 minutes.
 

Dolby Laboratories Inc

NYSE: DLB
Last

(U.S.) $40.17

Today's change0.00 0.00%
Updated January 26 4:02 PM EST. Delayed by at least 15 minutes.

Dolby Laboratories Inc closed at (U.S.)$40.17.

Shares have lost 4.29% over the last five days, but are unchanged over the last 52 weeks. This security has underperformed the S&P 500 by 17.66% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $40.17
  • High--
  • Low--
  • Bid / Ask(U.S.) $36.35 / (U.S.) $43.87
  • YTD % change-6.84%
  • Volume0
  • Average volume (10-day)516,974
  • Average volume (1-month)353,493
  • Average volume (3-month)342,200
  • 52-week range(U.S.) $37.25 to (U.S.) $47.29
  • Beta0.96
  • Trailing P/E20.54×
  • P/E 1 year forward25.72×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $0.40
  • Dividend yield1.00%
  • Trailing EPS(U.S.) $1.96
Updated January 26 4:02 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+21.33%

Based on its net profit margin of 21.33%, Dolby Laboratories Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.00%Sector:Cyclical Consumer Goods & ServicesIndustry:Entertainment Production
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2015Q4/2014Q3/2014Q2/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 26, 201412/26/2014Sep 26, 201409/26/2014Jun 27, 201406/27/2014Mar 28, 201403/28/2014
Revenue234227223279
Total other revenue--------
Total revenue234227223279
Gross profit215215204261
Total cost of revenue19121918
Total operating expense181169173174
Selling / general / administrative113109108111
Research & development49474745
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)00-10
Other operating expenses, total--------
Operating income545851105
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax546152103
Income after tax42464177
Income tax, total12141126
Net income41464076
Total adjustments to net income--------
Net income before extra. items41464076
Minority interest-10-1-1
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items41464076
Inc. avail. to common incl. extra. items41464076
Diluted net income42464076
Dilution adjustment000--
Diluted weighted average shares104104104104
Diluted EPS excluding extraordinary itemsvalue per share0.400.440.380.73
Dividends per sharevalue per share0.100.000.000.00
Diluted normalized EPSvalue per share0.400.440.380.73